These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 33363165)

  • 21. An overview of the neurological aspects in COVID-19 infection.
    Singh D; Singh E
    J Chem Neuroanat; 2022 Jul; 122():102101. PubMed ID: 35430271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
    Murta V; Villarreal A; Ramos AJ
    ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of COVID-19 and neurological complications.
    Hosseini N; Nadjafi S; Ashtary B
    Rev Neurosci; 2021 Aug; 32(6):671-691. PubMed ID: 33583157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurological complications and infection mechanism of SARS-COV-2.
    Wan D; Du T; Hong W; Chen L; Que H; Lu S; Peng X
    Signal Transduct Target Ther; 2021 Nov; 6(1):406. PubMed ID: 34815399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bifacial weakness with paresthesia – a rare Guillain–Barré syndrome subtype associated with SARS-CoV-2 infection].
    Gaál T; Szeszák G; Torák G; Salacz P
    Orv Hetil; 2021 Nov; 162(45):1803-1807. PubMed ID: 34747359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crosstalk Between Covid-19 and Associated Neurological Disorders: A Review.
    Ramachandran AK; Das S; Joseph A
    Curr Neuropharmacol; 2021; 19(10):1688-1700. PubMed ID: 33441073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation.
    Keyhanian K; Umeton RP; Mohit B; Davoudi V; Hajighasemi F; Ghasemi M
    J Neuroimmunol; 2020 Nov; 350():577436. PubMed ID: 33212316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental Issues and Neurological Manifestations Associated with COVID-19 Pandemic: New Aspects of the Disease?
    Bellocchio L; Bordea IR; Ballini A; Lorusso F; Hazballa D; Isacco CG; Malcangi G; Inchingolo AD; Dipalma G; Inchingolo F; Piscitelli P; Logroscino G; Miani A
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33139595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports.
    Najjar S; Najjar A; Chong DJ; Pramanik BK; Kirsch C; Kuzniecky RI; Pacia SV; Azhar S
    J Neuroinflammation; 2020 Aug; 17(1):231. PubMed ID: 32758257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 and Neurology: An Emerging Association.
    Gupta A; Yadav P; Kumar D
    Infect Disord Drug Targets; 2021; 21(8):e160921191570. PubMed ID: 33602080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurological Complications Associated With SARS-CoV-2 Infection: A Single-Centre Experience.
    Martins M; Pereira A; Teixeira A; Lima D; Lopes N; Amaral-Silva M; Seixo I; Miguéns AC
    Cureus; 2022 Dec; 14(12):e32655. PubMed ID: 36654564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurological Complications of COVID-19: Underlying Mechanisms and Management.
    Shehata GA; Lord KC; Grudzinski MC; Elsayed M; Abdelnaby R; Elshabrawy HA
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic Episodes on SARS-CoV-2-Mediated Neurological Manifestations and Their Possible Therapeutic Interventions.
    Nida S; Srinivisan H; Pandurangan AK; Waseem M
    J Environ Pathol Toxicol Oncol; 2022; 41(1):85-98. PubMed ID: 35378006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neurological significance of COVID-19: Lesson learn from the pandemic.
    Faried A; Dian S; Halim D; Hermanto Y; Pratama DMA; Arifin MZ
    Interdiscip Neurosurg; 2020 Dec; 22():100809. PubMed ID: 33520665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
    Zhou Z; Kang H; Li S; Zhao X
    J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurological manifestations and pathogenic mechanisms of COVID-19.
    Galea M; Agius M; Vassallo N
    Neurol Res; 2022 Jul; 44(7):571-582. PubMed ID: 34986754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurological manifestations of coronavirus disease 2019: exploring past to understand present.
    Desai I; Manchanda R; Kumar N; Tiwari A; Kumar M
    Neurol Sci; 2021 Mar; 42(3):773-785. PubMed ID: 33428055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Direct and indirect neurological manifestations of COVID-19].
    Gromova OA; Torshin IY; Semenov VA; Putilina MV; Chuchalin AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(11):11-21. PubMed ID: 33340292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Neurological Complexities and Prognosis of COVID-19.
    Padda I; Khehra N; Jaferi U; Parmar MS
    SN Compr Clin Med; 2020; 2(11):2025-2036. PubMed ID: 33015552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.